Vera Therapeutics, Inc. Operating Income (Loss) in USD from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vera Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2025.
  • Vera Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$83.9M, a 68.5% decline year-over-year.
  • Vera Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$270M, a 86% decline year-over-year.
  • Vera Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$167M, a 63.9% decline from 2023.
  • Vera Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$102M, a 12.2% decline from 2022.
  • Vera Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$90.9M, a 164% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Vera Therapeutics, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$270M -$83.9M -$34.1M -68.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 -$236M -$80.1M -$42.8M -115% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 -$193M -$57.2M -$26.1M -83.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 -$167M -$48.9M -$21.9M -81% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 -$145M -$49.8M -$28M -129% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 -$117M -$37.3M -$15.4M -70% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 -$102M -$31.1M +$146K +0.47% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 -$102M -$27M +$6.55M +19.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 -$109M -$21.8M +$3.49M +13.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$112M -$22M -$6.91M -45.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$105M -$31.3M -$14.2M -83.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$90.9M -$33.6M -$17M -102% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$73.9M -$25.2M -$18M -248% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$55.9M -$15.1M -$9.21M -157% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$46.7M -$17M -$12.3M -261% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$34.4M -$16.6M +$26M +61% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$60.4M -$7.25M -$3.22M -79.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$57.2M -$5.85M -$2.68M -84.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$54.5M -$4.72M -$2.25M -90.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$52.2M -$42.6M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$4.04M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$3.17M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$2.47M Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-24

Vera Therapeutics, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$167M -$65.2M -63.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 -$102M -$11.1M -12.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 -$90.9M -$56.5M -164% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$34.4M +$17.8M +34.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$52.2M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.